Skip to main
University-wide Navigation

Markey Receives ACS Grant to Remove Transportation Barriers for Patients

The funds from the American Cancer Society will help alleviate the financial burden of transportation costs for cancer patients throughout Kentucky.

Markey Study Shows Nutrient-Regulated Hormone Alters Stem Cell Function

A new study from the lab of Markey Cancer Director Mark Evers, M.D., demonstrates the critical role of the hormone neurotensin in cell proliferation and stem cell function in the small intestine.

UK Study Shows Combination Therapy May Potentially Improve Ovarian Cancer Patient Outcomes

A recent study demonstrates that a combination of two drugs used together provides better than expected results, providing a promising treatment strategy for patients with recurrent ovarian cancer.

Lt. Gov. Coleman, Female Legislators Highlight UK’s Ovarian Cancer Screening Program

Lt. Gov. Coleman and several of Kentucky’s female legislators joined UK HealthCare to highlight the work of the Markey Cancer Center's Ovarian Cancer Screening Program.

New Markey Initiative Helps Affiliates Deliver Cancer Care Closer to Home

The initiative aims to create a connected, integrated statewide cancer provider network. 40% of all new cancer cases in Kentucky are directly or indirectly cared for by Markey.

Preventing Cancer Recurrence with Coffee? Markey Launches Unique Clinical Trial

The UK Markey Cancer Center has officially launched a unique new clinical trial to test whether Artemisia annua extract can prevent ovarian cancer recurrence.

Markey’s ACTION Program Develops Cancer Education Curriculum for Appalachian Schools

The curriculum includes information on cancer data and risk factors in the region, follows national and state science and health education standards, and is tailored to cultural aspects of Appalachian Kentucky.

Markey Joins Nationwide Effort to Encourage Resumption of Cancer Screening, Treatment

The University of Kentucky Markey Cancer Center is teaming up with the National Comprehensive Cancer Network® (NCCN®), the American Cancer Society (ACS) and other leading cancer organizations across the country to endorse the resumption of cancer screening and treatment during the ongoing COVID-19 pandemic.

Markey Study Shows Kentucky Endometrial Cancer Patients Have Higher Rates of DACH1 Mutation

A new study by UK Markey Cancer Center researchers shows that DACH1 mutations are prevalent in Kentucky patients with endometrial cancer, suggesting that DACH1 may be a candidate biomarker for future trials with immunotherapy.

Williams Named Assistant Director for Cancer Health Equity at Markey

A major initiative of Williams and the Markey Community Impact Office will be the organization and expansion of Markey’s research and outreach portfolio that is focused on reducing cancer and other health disparities based on race/ethnicity, socioeconomic status, etc.

Filter News